Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study

Submitted by Viola Mäkelä on Mon, 12/04/2023 - 09:53
  • Read more about Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study

Central corneal thickness and the risk of primary open-angle glaucoma: a Mendelian randomisation mediation analysis

Submitted by Viola Mäkelä on Mon, 12/04/2023 - 08:57
  • Read more about Central corneal thickness and the risk of primary open-angle glaucoma: a Mendelian randomisation mediation analysis

Polygenic risk scores as a marker for epilepsy risk across lifetime and after unspecified seizure events

Submitted by Viola Mäkelä on Mon, 12/04/2023 - 08:48
  • Read more about Polygenic risk scores as a marker for epilepsy risk across lifetime and after unspecified seizure events

The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes

Submitted by Viola Mäkelä on Mon, 12/04/2023 - 08:30
  • Read more about The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes

Genetic causal relationship between gut microbiome and psoriatic arthritis: a bidirectional two-sample Mendelian randomization study

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 16:08
  • Read more about Genetic causal relationship between gut microbiome and psoriatic arthritis: a bidirectional two-sample Mendelian randomization study

Effects of gut microbiota on prostatic cancer: a two-sample Mendelian randomization study

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 16:06
  • Read more about Effects of gut microbiota on prostatic cancer: a two-sample Mendelian randomization study

Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 16:04
  • Read more about Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study

Investigating the gut microbiota's influence on psoriasis and psoriatic arthritis risk: a Mendelian randomization analysis

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 16:00
  • Read more about Investigating the gut microbiota's influence on psoriasis and psoriatic arthritis risk: a Mendelian randomization analysis

No causal effect of genetically determined circulating homocysteine levels on psoriasis in the European population: evidence from a Mendelian randomization study

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 15:42
  • Read more about No causal effect of genetically determined circulating homocysteine levels on psoriasis in the European population: evidence from a Mendelian randomization study

Genetically Predicted Causal Effects of Gut Microbiota and Gut Metabolites on Digestive Tract Cancer: A Two-Sample Mendelian Randomization Analysis

Submitted by Viola Mäkelä on Fri, 12/01/2023 - 15:39
  • Read more about Genetically Predicted Causal Effects of Gut Microbiota and Gut Metabolites on Digestive Tract Cancer: A Two-Sample Mendelian Randomization Analysis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 305
  • Page 306
  • Page 307
  • Page 308
  • Current page 309
  • Page 310
  • Page 311
  • Page 312
  • Page 313
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement